哈佛生物科学报告Q1损失,收入下降9%,但预测到2025年Q1将略有增长。 Harvard Bioscience reports Q1 loss, revenue down 9%, but forecasts modest growth for Q1 2025.

哈佛生物科学公司报告,每分得Q1收入0.04美元,损失的估计数为0.03美元。 Harvard Bioscience reported Q1 earnings per share of $0.04, missing estimates by $0.03. 该公司的收入在2024年下降了9%,降至9 410万美元,原因是全球市场困难,支出减少。 The company experienced a 9% revenue decline to $94.1 million in 2024, citing a difficult global market and reduced spending. 尽管损失净额为1 240万美元,但该公司预计2025年的Q1收入在1 900万至2 100万美元之间,这突显了对新产品的强烈接受和对成本管理的重视。 Despite a net loss of $12.4 million, the company expects Q1 2025 revenues between $19 million to $21 million, highlighting strong reception of new products and a focus on cost management.